论文部分内容阅读
目的分析利凡诺用于妊娠中期计划分娩用与不用息隐计划分娩效果的差异,了解小剂量息隐配伍利凡诺用于妊娠中期计划分娩的效果。方法将妊娠中期计划分娩产妇随机分为2组,配伍息隐组100例,第1、2天息隐25mg,2次/d口服,第3天利凡诺100mg羊膜腔内注射,对照组60例,单用利凡诺100mg羊膜腔内注射。观察自羊膜腔注射后胎儿排出时间、阴道流血量、清宫率及胎盘胎膜残留情况。结果配伍小剂量息隐组自羊膜腔注射后胎儿排出时间平均为(16.25±3.18)h,对照组平均为(36.28±3.16)h,差异有统计学意义(P<0.01),观察组清宫率低于对照组清宫率;观察组计划分娩成功率高于对照组计划分娩成功率。结论小剂量息隐配伍利凡诺用于妊娠中期计划分娩具有成功率高、流血量少、时间短、并发症少、清宫率低等优点,效果安全可靠,值得临床工作中广泛推广应用。
Objective To analyze the effect of Rivanol on the planned delivery of labor in the second trimester of pregnancy and the effect of planned delivery with low dose of interest. Methods Midwifery program delivery women were randomly divided into two groups, with compatibility of Yin hidden group of 100 cases, the first and second days of interest hidden 25mg, 2 times / d orally, the first 3 days of rivanol 100mg amniotic cavity injection, the control group 60 Cases, single rivanol 100mg amniotic cavity injection. Observed since the amniotic cavity after injection of fetal discharge time, vaginal bleeding, clearance rate and residual placental membranes. Results The results showed that the average discharge time of fetus after injection of amniotic fluid in small dose and interest group was (16.25 ± 3.18) h and that in control group was (36.28 ± 3.16) h, the difference was statistically significant (P0.01) Lower than that of the control group; the success rate of planned delivery in observation group was higher than that of planned delivery in control group. Conclusions The low dose of phenylephrine compatibility rivanol has the advantages of high success rate, less blood loss, shorter time, fewer complications and lower rate of hysteroscopy in mid pregnancy. It is safe and reliable, and it is worth to be widely applied in clinical practice.